Verastem, Inc. (VSTM)
5.31
+0.22
(+4.32%)
USD |
NASDAQ |
Mar 26, 13:31
Verastem Free Cash Flow : -147.13M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Altimmune, Inc. | -67.55M |
| ADMA Biologics, Inc. | 27.50M |
| Ocugen, Inc. | -57.15M |
| Zevra Therapeutics, Inc. | -2.433M |
| Immuneering Corp. | -45.49M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -29.95M |
| Cash from Investing (Quarterly) | -1.345M |
| Cash from Financing (Quarterly) | 98.58M |
| Free Cash Flow Per Share (Quarterly) | -0.3753 |
| Free Cash Flow to Equity (Quarterly) | -28.99M |
| Free Cash Flow to Firm (Quarterly) | -30.88M |
| Free Cash Flow Yield | -38.92% |